Literature DB >> 235062

Renal vascular tone in essential and secondary hypertension: hemodynamic and angiographic responses to vasodilators.

N K Hollenberg, D F Adams, H Solomon, W R Chenitz, B M Burger, H L Abrams, J P Merrill.   

Abstract

The renal vascular response to graded doses of acetylcholine, dopamine and phentolamine, assessed by xenon washout and selective arteriography was used to define the relative contribution of fixed and reversible vascular abnormalities to increased renal vascular resistance in patients with essential or secondary hypertension. The increase in blood flow induced by acetylcholine and dopamine was blunted strikingly in patients with advanced nephrosclerosis, chronic pyelonephritis and polycystic kidney disease and was normal in the kidney contralateral to a significant renal artery stenosis. Conversely, the response to both was potentiated in 9 of 13 (69%) patients with mild essential hypertension. Equivalent potentiation of the response to acetylcholine was induced in normal subjects by increasing renal vascular tone pharmacologically with angiotensin. Phentolamine infused into the renal artery also increased renal blood flow significantly in 6 of 9 (67%) patients with mild essential hypertension, but in none of 15 normal subjects, over a dose reange that paralleled that for alpha-adrenergic blockade. Changes in the selective renal arteriogram were in excellent accord: potentiated response to acetylcholine, phentolamine or dopamine was associated with reversal of the small vessel abnormalities visualized in the arteriogram. The reduced blood flow response in advanced nephrosclerosis or parenchymal disease was associated with a reduced angiographic change during dilator infusion. The results suggest a quantitatively important, functional renal vascular abnormality--perhaps mediated by the sympathetic nervous system--in many patients with mild essential hypertension. Conversely the renal vascular abnormality associated with advanced nephrosclerosis or renal parenchymal disease is largely fixed and is probably due to organic changes.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235062     DOI: 10.1097/00005792-197501000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  15 in total

1.  Effects of diadenosine polyphosphates on glomerular volume.

Authors:  Miroslawa Szczepańska-Konkel; Maciej Jankowski; Anna Stiepanow-Trzeciak; Stefan Angielski
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

2.  Renal and hormonal effects of alpha 1-adrenoceptor blockade by bunazosin in essential hypertension.

Authors:  Y Hirata; K Fukui; Y Dan; H Matsuoka; T Sugimoto; M Ishii
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 3.  The role of the kidney and the sympathetic nervous system in hypertension.

Authors:  Philip Thomas; Indranil Dasgupta
Journal:  Pediatr Nephrol       Date:  2014-03-08       Impact factor: 3.714

Review 4.  Interrelationship between renal haemodynamics, drug kinetics and drug action.

Authors:  K L Duchin; R W Schrier
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

5.  [The importance of changes in whole-body balance of sodium and noradrenaline in essential hypertension (author's transl)].

Authors:  R Lang; A Maxrath; U Laaser; K A Meurer; W Kaufmann
Journal:  Klin Wochenschr       Date:  1978-11-15

6.  beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation.

Authors:  N K Hollenberg; D F Adams; D N McKinstry; G H Williams; L J Borucki; J M Sullivan
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

7.  Peripheral renal vascular disease in essential hypertension: hemodynamic, angiographic, and endocrine assessment.

Authors:  I P Arlart; J Rosenthal
Journal:  Cardiovasc Intervent Radiol       Date:  1984       Impact factor: 2.740

8.  Somatosensory regulation of renal function in the stroke-prone spontaneously hypertensive rat.

Authors:  G Davis; E J Johns
Journal:  J Physiol       Date:  1994-12-15       Impact factor: 5.182

Review 9.  Renal effects of antihypertensive drugs.

Authors:  W A Schlueter; D C Batlle
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 10.  Acute and chronic effects of angiotensin converting enzyme inhibitors on the essential hypertensive kidney.

Authors:  G P Reams; J H Bauer
Journal:  Cardiovasc Drugs Ther       Date:  1990-02       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.